99 related articles for article (PubMed ID: 6630076)
1. Taxonomy of actinomycetes capable of hydroxylation of ML-236B (compactin).
Okazaki T; Serizawa N; Enokita R; Torikata A; Terahara A
J Antibiot (Tokyo); 1983 Sep; 36(9):1176-83. PubMed ID: 6630076
[TBL] [Abstract][Full Text] [Related]
2. Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B.
Serizawa N; Serizawa S; Nakagawa K; Furuya K; Okazaki T; Terahara A
J Antibiot (Tokyo); 1983 Jul; 36(7):887-91. PubMed ID: 6684108
[TBL] [Abstract][Full Text] [Related]
3. Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B).
Serizawa N; Nakagawa K; Hamano K; Tsujita Y; Terahara A; Kuwano H
J Antibiot (Tokyo); 1983 May; 36(5):604-7. PubMed ID: 6874577
[No Abstract] [Full Text] [Related]
4. 3 alpha-Hydroxy-ML-236B (3 alpha-hydroxycompactin), microbial transformation product of ML-236B (compactin).
Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H
J Antibiot (Tokyo); 1983 May; 36(5):608-10. PubMed ID: 6874578
[No Abstract] [Full Text] [Related]
5. Formation of dihydroxy derivative of ML-236B from ML-236B (compactin) by lipid peroxidation.
Serizawa N; Nakahara K; Matsuoka T
J Antibiot (Tokyo); 1990 Aug; 43(8):1031-3. PubMed ID: 2120167
[No Abstract] [Full Text] [Related]
6. Microbial hydroxylation of compactin (ML-236B) and monacolin K.
Yamashita H; Tsubokawa S; Endo A
J Antibiot (Tokyo); 1985 May; 38(5):605-9. PubMed ID: 4040510
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
[TBL] [Abstract][Full Text] [Related]
8. Microbial phosphorylation of compactin (ML-236B) and related compounds.
Endo A; Yamashita H; Naoki H; Iwashita T; Mizukawa Y
J Antibiot (Tokyo); 1985 Mar; 38(3):328-32. PubMed ID: 4008328
[TBL] [Abstract][Full Text] [Related]
9. Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin.
Chen CH; Hu HY; Cho YC; Hsu WH
Curr Microbiol; 2006 Aug; 53(2):108-12. PubMed ID: 16802209
[TBL] [Abstract][Full Text] [Related]
10. Microbial conversion of milbemycins: 30-oxidation of milbemycin A4 and related compounds by Amycolata autotrophica and Amycolatopsis mediterranei.
Nakagawa K; Torikata A; Sato K; Tsukamoto Y
J Antibiot (Tokyo); 1990 Oct; 43(10):1321-8. PubMed ID: 2258330
[TBL] [Abstract][Full Text] [Related]
11. 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H; Tanaka M
J Antibiot (Tokyo); 1983 Jul; 36(7):918-20. PubMed ID: 6549610
[No Abstract] [Full Text] [Related]
12. Microbial conversion of compactin (ML-236B) to ML-236A.
Komagata D; Yamashita H; Endo A
J Antibiot (Tokyo); 1986 Nov; 39(11):1574-7. PubMed ID: 3793626
[TBL] [Abstract][Full Text] [Related]
13. L-669,262, a potent HMG-CoA reductase inhibitor.
Joshua H; Schwartz MS; Wilson KE
J Antibiot (Tokyo); 1991 Mar; 44(3):366-70. PubMed ID: 2026562
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of yeast by compactin (ML-236B) analogues.
Ikeura R; Murakawa S; Endo A
J Antibiot (Tokyo); 1988 Aug; 41(8):1148-50. PubMed ID: 3170348
[No Abstract] [Full Text] [Related]
16. Nocardia lijiangensis sp. nov., a novel actinomycete strain isolated from soil in China.
Xu P; Li WJ; Tang SK; Jiang Y; Gao HY; Xu LH; Jiang CL
Syst Appl Microbiol; 2006 Jun; 29(4):308-14. PubMed ID: 16337766
[TBL] [Abstract][Full Text] [Related]
17. Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor.
Fujii Y; Norihisa K; Fujii T; Aritoku Y; Kagawa Y; Sallam KI; Johdo O; Arisawa A; Tamura T
Biochem Biophys Res Commun; 2011 Jan; 404(1):511-6. PubMed ID: 21144838
[TBL] [Abstract][Full Text] [Related]
18. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Serizawa N; Matsuoka T
Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
[TBL] [Abstract][Full Text] [Related]
19. [Systematic position of an autotrophic actinomycete isolated from a floodplain marsh near Moscow].
Kuznetsov VD; Kriukov VR; Rodionova EG; Filippova SN
Mikrobiologiia; 1978; 47(1):107-11. PubMed ID: 651680
[TBL] [Abstract][Full Text] [Related]
20. Transvalencin A, a thiazolidine zinc complex antibiotic produced by a clinical isolate of Nocardia transvalensis. I. Taxonomy, fermentation, isolation and biological activities.
Hoshino Y; Mukai A; Yazawa K; Uno J; Ishikawa J; Ando A; Fukai T; Mikami Y
J Antibiot (Tokyo); 2004 Dec; 57(12):797-802. PubMed ID: 15745114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
